home / stock / txg / txg news


TXG News and Press, 10x Genomics Inc. From 11/02/22

Stock Information

Company Name: 10x Genomics Inc.
Stock Symbol: TXG
Market: NYSE
Website: 10xgenomics.com

Menu

TXG TXG Quote TXG Short TXG News TXG Articles TXG Message Board
Get TXG Alerts

News, Short Squeeze, Breakout and More Instantly...

TXG - 10x Genomics GAAP EPS of -$0.37 beats by $0.11, revenue of $131.07M beats by $1.94M

10x Genomics press release ( NASDAQ: TXG ): Q3 GAAP EPS of -$0.37 beats by $0.11 . Revenue of $131.07M (+4.6% Y/Y) beats by $1.94M . Cash and cash equivalents and marketable securities were $452.4 million as of September 30, 2022. 2022 Guidance: ...

TXG - 10x Genomics Reports Third Quarter 2022 Financial Results

10x Genomics Reports Third Quarter 2022 Financial Results PR Newswire PLEASANTON, Calif. , Nov. 2, 2022 /PRNewswire/ -- 10x Genomics, Inc. (Nasdaq: TXG) today reported financial results for the third quarter ended September 30, 2022. ...

TXG - 10x Genomics to Host Investor Day on December 8, 2022

10x Genomics to Host Investor Day on December 8, 2022 PR Newswire PLEASANTON, Calif. , Oct. 31, 2022 /PRNewswire/ -- 10x Genomics (Nasdaq: TXG) today announced it will host an Investor Day on December 8, 2022 at the company's headquarters in Pleasanton, CA ...

TXG - Tracking Baillie Gifford's 13F Portfolio - Q3 2022 Update

Summary Baillie Gifford’s 13F portfolio value decreased from ~$97.51B to ~$96.99B this quarter. They increased Shopify, Roblox, Zoom Video, and Twilio while reducing Albemarle Corporation and Li Auto ADR. The top three positions are Tesla Motors, Moderna, and MercadoLib...

TXG - Tracking Cathie Wood's ARK Invest 13F Portfolio - Q3 2022 Update

Summary ARK Invest’s 13F portfolio value decreased from $16.91B to $14.35B this quarter. UiPath, Ginkgo Bioworks, and NVIDIA were increased while decreasing Spotify, Ionis Pharma, CRISPR Therapeutics, and Coinbase Global. The top three positions are Tesla Inc., Zoom Vid...

TXG - 10x Genomics to Report Third Quarter Financial Results on November 2, 2022

10x Genomics to Report Third Quarter Financial Results on November 2, 2022 PR Newswire PLEASANTON, Calif. , Oct. 12, 2022 /PRNewswire/ -- 10x Genomics (Nasdaq: TXG) today announced it will report financial results for the third quarter 2022 after mar...

TXG - 10x Genomics: No Signs Of A Growth Turnaround, Heavy Bearish Momentum

Summary The Health Care sector and Biotech niche have both been interesting sources of relative market strength in recent months; one defensive, one more risk-on. 10x Genomics was a massive winner around the Covid-19 pandemic, but an improving health situation around the world pos...

TXG - Stocks And Sectors With The Biggest Declines

Summary The average stock in the Russell 3,000 was down 41.7% from its 52-week high as of the close on Monday. Four sectors have average prices roughly 50% below their 52-week highs - Communication Services at -51.8%, Consumer Discretionary at -49.8%, Tech at -49.4%, and Health Ca...

TXG - Tracking Al Gore's Generation Investment Management Portfolio - Q2 2022 Update

Summary Generation Investment Management’s 13F portfolio value decreased from $21.84B to $18.35B this quarter. They added Mastercard and increased Amazon.com, Microsoft, Trane Technologies, and Analog Devices while reducing Baxter International, Becton Dickinson, and Alphab...

TXG - 10x Genomics to Present at the Morgan Stanley 20th Annual Global Healthcare Conference

10x Genomics to Present at the Morgan Stanley 20th Annual Global Healthcare Conference PR Newswire PLEASANTON, Calif. , Sept. 2, 2022 /PRNewswire/ -- 10x Genomics, Inc. (Nasdaq: TXG), a life sciences leader focused on mastering biology to advance human he...

Previous 10 Next 10